2014
DOI: 10.1136/neurintsurg-2014-011458
|View full text |Cite
|
Sign up to set email alerts
|

Stroke recurrence rates among patients with symptomatic intracranial vertebrobasilar stenoses: systematic review and meta-analysis

Abstract: Our results showed that the risk of stroke recurrence or death or the risk of stroke recurrence alone was comparable between the medical and endovascular therapy groups. A small preventive effect of endovascular therapy may exist, particularly if the 30 day postprocedural risk is reduced.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

4
34
1

Year Published

2015
2015
2023
2023

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 38 publications
(39 citation statements)
references
References 34 publications
4
34
1
Order By: Relevance
“…Antiplatelet function testing by thromboelastography revealed no abnormalities. The 30-day stroke and mortality rate in our study was 5.2%, similar to the 6.3% from Jiang's study on intracranial posterior circulation stenting [10] and the 6.5% from a meta-analysis [4]. It was lower than the 14.7% of the endovascular arm in SAMMPRIS [2] and the rate of 10.8-13.8% from a review of published studies of intervention for the intracranial vertebrobasilar system [16].…”
Section: Discussionsupporting
confidence: 84%
See 1 more Smart Citation
“…Antiplatelet function testing by thromboelastography revealed no abnormalities. The 30-day stroke and mortality rate in our study was 5.2%, similar to the 6.3% from Jiang's study on intracranial posterior circulation stenting [10] and the 6.5% from a meta-analysis [4]. It was lower than the 14.7% of the endovascular arm in SAMMPRIS [2] and the rate of 10.8-13.8% from a review of published studies of intervention for the intracranial vertebrobasilar system [16].…”
Section: Discussionsupporting
confidence: 84%
“…Although the controversial SAMMPRIS study did not demonstrate superiority of endovascular treatment over medical treatment, most of the ischemic events in SAMMPRIS and in a recent meta-analysis of intracranial vertebrobasilar intervention occurred perioperatively [3,4]. These results can be interpreted as a low perioperative risk being imperative to improve the risk-benefit ratio of endovascular treatment over medical treatment.…”
Section: Introductionmentioning
confidence: 90%
“…Our study also shows more than 50% of favorable outcomes on mRS (75.0% of relevant favorable outcomes on mRS) in patients with atherosclerotic BA steno-occlusion. This statistic is comparable to the study by Abuzinadah et al (16), in which the stroke recurrence rate in the symptomatic vertebrobasilar stenosis group who were treated medically was 9.6%/year and in the endovascular group was 7.2%/year. Vertebrobasilar stenosis is associated with a stroke recurrence risk that varies between 2.5-5.5% and 10-15% per year (17).…”
Section: Resultssupporting
confidence: 78%
“…Posterior circulation strokes comprise approximately 20-25% of all strokes of ischemic origin. Strokes affecting this area carry a significantly higher risk for subsequent stroke or death as compared to anterior circulation strokes in the acute phase [7 days following initial stroke or transient ischemic attack (TIA)] [4,5]. …”
Section: Introductionmentioning
confidence: 99%